Review
Copyright ©2010 Baishideng Publishing Group Co.
World J Cardiol. Sep 26, 2010; 2(9): 280-288
Published online Sep 26, 2010. doi: 10.4330/wjc.v2.i9.280
Table 2 Reported prevalence of “aspirin resistance”
Prevalence (%)Ref.
Healthy adults8.3[38]
Risk factors0.7-23.4[39,40]
Stable CAD0.4-29.2[41-48]
CVD12.5-56[49-55]
CABG7.1-54[56-60]
PCI12.7-26.2[61-64]
MI0.5-70.1[65-70]
CHF55.0[71]
PVD9.6-60[72,73]